Search - tctmd.com

Displaying 41 - 60 of 70

$Tricuspid Sapien 3 Valve in Incomplete Ring Followed by ASO Closure of Severe PVL for Severe TR and Refractory Right Sided Heart Failure$

Presentation TVT 2017

Tricuspid Sapien 3 Valve in Incomplete Ring Followed by ASO Closure of Severe PVL for Severe TR and Refractory Right Sided Heart Failure

Presenter: Azeem Latib, Christopher U. Meduri, Elliott Groves, MD

June 15, 2017

Presentation TVT 2017

Transfemoral Aortic Valve Replacement With a SAPIEN-3 Heart Valve in a Patient With Severe Scoliosis: A Roller Coaster Ride

Presenter: Albert Markus Kasel, Thomas Walther, Etienne Couture, MD

June 15, 2017

News Conference News TVT 2017

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

Shelley Wood

June 12, 2017

News Daily News

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Michael O'Riordan

June 06, 2017

Presentation

Outcomes With Boston Scientific Lotus Valve and Edwards Lifesciences Sapien 3

June 06, 2017

News Daily News

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Michael O'Riordan

June 06, 2017

News Conference News EuroPCR 2017

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

Michael O'Riordan

May 26, 2017

News Conference News EuroPCR 2017

More Early Stroke With SAVR Than TAVR in SURTAVI

Shelley Wood

May 18, 2017

News Conference News EuroPCR 2017

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

Michael O'Riordan

May 17, 2017

News Conference News EuroPCR 2017

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

Shelley Wood

May 17, 2017

News Conference News EuroPCR 2017

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Yael L. Maxwell

May 17, 2017

News Daily News

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Shelley Wood

May 02, 2017

News Daily News

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Yael L. Maxwell

April 18, 2017

News Daily News

Conscious Sedation in TAVR Cuts Costs by 25%, Boosts Patient Satisfaction

Shelley Wood

April 13, 2017

News Daily News

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

L.A. McKeown

April 12, 2017

Presentation

A Highly Predictive Risk Model for New Permanent Pacemaker Implantation After Sapien 3 TAVR

April 12, 2017

News Conference News ACC 2017

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Shelley Wood

March 24, 2017

News Conference News ACC 2017

Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI

Caitlin E. Cox

March 20, 2017

News Conference News ACC 2017

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Michael O'Riordan

March 19, 2017

Presentation SIF 2017

Best Practices: Sapien 3

Presenter: Samir Kapadia

March 11, 2017

Advertisement

Tricuspid Sapien 3 Valve in Incomplete Ring Followed by ASO Closure of Severe PVL for Severe TR and Refractory Right Sided Heart Failure

Transfemoral Aortic Valve Replacement With a SAPIEN-3 Heart Valve in a Patient With Severe Scoliosis: A Roller Coaster Ride

Q&A: Transcatheter Valve Innovation Past, Present, and Future as TVT Turns 10

FDA Expands Sapien 3 Indication to Aortic, Mitral Valve-in-Valve Replacement

Outcomes With Boston Scientific Lotus Valve and Edwards Lifesciences Sapien 3

Lotus Matches Sapien in Single-Center Study, but Pacemaker Use Poses Questions

Embolic Protection During TAVR Reduces Volume of Cerebral Lesions, but Clinical Benefit Not Evident: Meta-analysis

More Early Stroke With SAVR Than TAVR in SURTAVI

Bicuspid AS Patients with Calcification Fare Worse After TAVR, But Device Type Matters

If They Survive First Month, Mitral Annular Calcification Patients Treated With Transcatheter Valves Do Well at 1 Year

The ARTE of Antiplatelet Therapy After TAVR: Bleeding Greater with Clopidogrel Plus Aspirin vs Aspirin Alone

Updated PARTNER 2 Valve-in-Valve Registry: More Experience, Better Outcomes

Novel Percutaneous Technique May Allow for TMVR in Patients at High Risk for LVOT Obstruction

Conscious Sedation in TAVR Cuts Costs by 25%, Boosts Patient Satisfaction

Permanent Pacemakers After TAVR: Model Helps Predict Individual Patient Risk With Sapien 3

A Highly Predictive Risk Model for New Permanent Pacemaker Implantation After Sapien 3 TAVR

TAVR for Bicuspid Aortic Stenosis? Registry Offers Clues to Safety, Outcomes

Post-TAVR, Nearly a Quarter of Patients Show New Signs of Silent Cerebral Microbleeds on MRI

Leaflet Thrombosis Common After Aortic Valve Implant, More So in TAVR Than in Surgery

Best Practices: Sapien 3

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content